Invega Hafyera and other medicines may affect each other causing possible serious side effects. Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. What other drugs will affect Invega Hafyera? Talk to your healthcare provider about the best way to feed your baby during treatment. Invega Hafyera can pass into your breast milk. are breastfeeding or plan to breastfeed.Tell your healthcare provider right away if your baby develops any of these symptoms. Babies born to mothers who receive Invega Hafyera during their third trimester of pregnancy may develop agitation, low muscle tone (floppy baby syndrome) tremors, excessive sleepiness, breathing problems, and feeding problems.You can register by calling 1-86 or visit research-programs/pregnancyregistry/. If you become pregnant during treatment, talk to your healthcare provider about registering with the National Pregnancy Registry for Atypical Antipsychotics.Tell your healthcare provider right away if you become pregnant or think you may be pregnant during treatment.It is not known if Invega Hafyera will harm your unborn baby. are pregnant or plan to become pregnant.have had problems with dizziness or fainting or are being treated for high blood pressure.have Parkinson’s disease or a type of dementia called Lewy Body Dementia.have diabetes or have a family history of diabetes.have or have had kidney or liver problems.have or have had uncontrolled movements of your tongue, face, mouth, or jaw (tardive dyskinesia).have or have had low levels of potassium or magnesium in your blood.have or have had heart problems, including a heart attack, heart failure, abnormal heart rhythm, or long QT syndrome.have had Neuroleptic Malignant Syndrome (NMS).Before receiving Invega Hafyeraīefore you start treatment, tell your healthcare provider about all your medical conditions, including if you: See the end of this page for a complete list of ingredients. You should not receive Invega Hafyera if you are allergic to paliperidone palmitate, risperidone, or any of the ingredients. Invega Hafyera is not for the treatment of people with dementia-related psychosis. Invega Hafyera increases the risk of death in elderly people who have lost touch with reality (psychosis) due to confusion and memory loss (dementia). Increased risk of death in elderly people with dementia-related psychosis.Invega Hafyera may cause serious side effects, including: It is not known if this medicine is safe and effective in children under 18 years of age. A 1 time every 3 months paliperidone palmitate extended-release injectable suspension for at least 3 months.A 1 time each month paliperidone palmitate extended-release injectable suspension for at least 4 months.
Invega Hafyera is a prescription medicine given by injection by a healthcare provider 1 time every 6 months and used for the treatment of schizophrenia in adults who have been adequately treated with either:
Medically reviewed by Judith Stewart, BPharm. Dosage Form: extended-release injectable suspension